Want to see AU:SHG full AI Analyst Report?
SHG Stock Chart & Stats
AU$0.26
AU$0.03(15.38%)
At close: 4:00 PM EST
AU$0.26
AU$0.03(15.38%)
Day’s Range― - ―
52-Week RangeAU$0.14 - AU$0.30
Previous CloseN/A
Volume808.83K
Average Volume (3M)320.73K
Market Cap
AU$52.17M
Enterprise ValueAU$59.43M
Total Cash (Recent Filing)AU$10.06M
Total Debt (Recent Filing)AU$109.96K
Price to Earnings (P/E)―
Beta0.86
Next Earnings
Feb 19, 2027EPS Estimate
>-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding326,091,300
10 Day Avg. Volume387,601
30 Day Avg. Volume320,734
Financial Highlights & Ratios
PEG Ratio0.47
Price to Book (P/B)6.53
Price to Sales (P/S)48.14
P/FCF Ratio-12.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.31Price Target Upside19.23% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)AU$4.93M
Bulls Say, Bears Say
Bulls Say
Revenue GrowthThe latest period shows meaningful revenue traction, indicating that Singular Health Group is generating greater commercial activity from its offerings. If this growth persists, it can improve operating leverage, broaden customer adoption, and provide a foundation for eventual profitability.
Lower LeverageA less leveraged balance sheet gives the company greater financial flexibility than in earlier periods, reducing near-term solvency pressure and limiting the burden of interest obligations. This provides more capacity to fund product development or withstand volatility while the business scales.
Healthcare Software FocusA focused model built around medical imaging software and digital health solutions gives Singular Health Group a clearly defined role in healthcare information services. Products supporting visualization, management, and interpretation can become embedded in clinical decision workflows over time.
Bears Say
Persistent UnprofitabilityNegative gross profit and deeply negative operating results show that the current revenue base is not yet covering the economics of the business. Without sustained improvement in pricing, delivery efficiency, or scale, continued losses could restrict reinvestment and weaken financial resilience.
Ongoing Cash BurnPersistent negative operating and free cash flow means the company is consuming cash rather than funding operations internally. Even with some improvement from 2025, continued burn can increase reliance on external capital and constrain the ability to invest consistently in growth.
Negative Shareholder ReturnsNegative return on equity across all reported periods indicates that shareholder capital has not yet generated positive returns. If losses continue, retained resources may be depleted over time, while the weak capital productivity can make future funding and compounding shareholder value more difficult.
SHG FAQ
What was Singular Health Group Ltd’s price range in the past 12 months?
Singular Health Group Ltd lowest share price was AU$0.14 and its highest was AU$0.30 in the past 12 months.
What is Singular Health Group Ltd’s market cap?
Singular Health Group Ltd’s market cap is AU$52.17M.
When is Singular Health Group Ltd’s upcoming earnings report date?
Singular Health Group Ltd’s upcoming earnings report date is Feb 19, 2027 which is in 115 days.
How were Singular Health Group Ltd’s earnings last quarter?
Singular Health Group Ltd released its earnings results on Aug 27, 2026. The company reported -AU$0.011 earnings per share for the quarter.
Is Singular Health Group Ltd overvalued?
According to Wall Street analysts Singular Health Group Ltd’s price is currently Undervalued.
Does Singular Health Group Ltd pay dividends?
Singular Health Group Ltd does not currently pay dividends.
What is Singular Health Group Ltd’s EPS estimate?
Singular Health Group Ltd’s EPS estimate is >-0.01.
How many shares outstanding does Singular Health Group Ltd have?
Singular Health Group Ltd has 326,091,300 shares outstanding.
What happened to Singular Health Group Ltd’s price movement after its last earnings report?
Singular Health Group Ltd reported an EPS of -AU$0.011 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Singular Health Group Ltd?
Currently, no hedge funds are holding shares in AU:SHG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Singular Health Group Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$0.31 (19.23% Upside)
AU$0.31 (19.23% Upside)
Blogger Sentiment
Bullish
AU:SHG Sentiment 92%
Sector Average 67%
Sector Average 67%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-40.74%
12-Months-Change
Fundamentals
Return on Equity
-57.06%
Trailing 12-Months
Asset Growth
-20.92%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Singular Health Group Ltd
Singular Health Group Ltd operates as a medical technology enterprise dedicated to developing and commercializing a volumetric rendering platform (VRP). This advanced platform facilitates the three-dimensional and virtual reality presentation of anatomy, drawing upon standard radiological imaging. Among its key offerings are the 3Dicom Viewer, a cross-compatible software application designed for users to engage with conventional 2D medical images; 3DicomVSP, a complete system for surgical planning; Health Academy, a adaptable, multi-language platform delivering structured, curriculum-aligned educational modules; and GeoVR, a cloud-based solution specifically engineered for the mineral resources industry. The company, founded in 2017, is headquartered in Subiaco, Australia.
SHG Stock 12 Month Forecast
Average Price Target
AU$0.31
▲(19.23% Upside)
Technical Analysis
Mach7 Technologies
―
Resonance Health Ltd
―
Beamtree Holdings Ltd
―
Artrya Limited
―
Alcidion Group Limited
―





